Inversago Pharma Appoints Glenn S. Vraniak as Chief Financial Officer
MONTREAL–(BUSINESS WIRE)–#CFO–Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, today announces the appointment of Glenn S. Vraniak to the position of Chief Financial Officer (CFO), effective immediately. Mr. Vraniak’s career spans more than 20 years of financial and commercial experience in the life sciences industry. Before … [Read more…]